Its expression in this context is itself regulated by the balance of microenvironmental signals, induced by pro-angiogenic factors like basic fibroblast growth factor (bFGF) from tumor cells and suppressed by endogenous inhibitors like angiostatin [147,149]. This evidence concerns the gene FGF2 and neoplasm.